Values First Advisors, Inc. Ascendis Pharma A/S Transaction History

Values First Advisors, Inc.

$182 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$86.1 - $127.36 $205,865 - $304,517	-2,391 Reduced 23.36%	7,844 $987,000
Q3 2023 Nov 08, 2023	BUY	$86.5 - $103.97 $27,161 - $32,646	314 Added 3.17%	10,235 $958,000
Q2 2023 Aug 02, 2023	BUY	$69.96 - $97.84 $176,089 - $246,263	2,517 Added 34.0%	9,921 $885,000
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $15,735 - $19,017	150 Added 2.07%	7,404 $793,000
Q4 2022 Jan 20, 2023	SELL	$99.42 - $131.97 $196,155 - $260,376	-1,973 Reduced 21.38%	7,254 $0
Q3 2022 Dec 02, 2022	SELL	$84.03 - $110.23 $277,467 - $363,979	-3,302 Reduced 26.35%	9,227 $953,000
Q2 2022 Jul 20, 2022	SELL	$78.08 - $117.61 $119,930 - $180,648	-1,536 Reduced 10.92%	12,529 $1.17 Million
Q1 2022 May 03, 2022	BUY	$102.18 - $135.75 $414,442 - $550,602	4,056 Added 40.52%	14,065 $1.65 Million
Q4 2021 Mar 10, 2022	BUY	$127.1 - $169.66 $1.27 Million - $1.7 Million	10,009 New	10,009 $1.35 Million
Q3 2021 Nov 15, 2022	BUY	$112.67 - $176.92 $150,865 - $236,895	1,339 Added 10.69%	13,868 $2.21 Million
Q2 2021 Nov 15, 2022	BUY	$121.62 - $145.29 $79,296 - $94,729	652 Added 6.31%	10,991 $1.45 Million
Q1 2021 Nov 15, 2022	SELL	$124.92 - $173.33 $273,574 - $379,592	-2,190 Reduced 17.48%	10,339 $1.33 Million
Q4 2020 Nov 15, 2022	BUY	$151.2 - $182.76 $114,155 - $137,983	755 Added 9.99%	8,316 $1.39 Million
Q3 2020 Nov 15, 2022	SELL	$134.29 - $154.32 $30,618 - $35,184	-228 Reduced 2.93%	7,561 $1.17 Million
Q2 2020 Nov 15, 2022	SELL	$110.87 - $156.01 $280,944 - $395,329	-2,534 Reduced 24.55%	7,789 $1.15 Million
Q1 2020 Jan 09, 2023	SELL	$97.01 - $145.11 $87,211 - $130,453	-899 Reduced 9.74%	8,328 $938 Million
Q4 2019 Nov 15, 2022	SELL	$91.45 - $139.12 $201,738 - $306,898	-2,206 Reduced 17.61%	10,323 $1.44 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Account